Table 3.
Patient number | Plasma | Urine | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPI | NE | DA | MN | NMN | MTY | CgA | EPI | NE | DA | MN | NMN | |
1 | – | – | – | – | – | – | – | – | – | – | – | – |
2 | – | + | + | + | + | + | + | – | + | + | – | + |
3 | – | – | + | – | – | + | + | – | + | – | – | + |
4 | + | – | + | – | – | + | – | – | – | – | – | – |
5 | – | – | + | – | – | – | + | – | + | – | + | + |
6 | – | – | – | – | – | – | – | – | – | – | – | + |
7 | – | + | + | + | + | + | * | – | + | + | – | + |
8 | – | – | – | – | + | – | + | – | – | – | – | – |
9 | + | – | – | – | + | + | + | – | – | – | – | – |
10 | – | – | – | – | – | + | + | – | – | – | – | – |
CgA, chromogranin A; DA, dopamine; EPI, epinephrine; MN, metanephrine; MTY, methoxytyramine; NE, norepinephrine; NMN, normetanephrine; +, above upper reference limit; -, within normal limits.
*,not available due to hemolysis of blood.